Symbiotec Pharmalab Limited IPO

Symbiotec Pharmalab Limited is listed in the MAINBOARD segment with a price band of ₹938 to ₹988. The figures below are as reported by the exchanges and public sources.

Symbiotec Pharmalab Limited IPO — key facts

• The Symbiotec Pharmalab Limited IPO price band is ₹938 to ₹988 per share.
• One lot is 15 shares, a minimum application of ₹14,820.
• As of 6 September 2026, the Symbiotec Pharmalab Limited IPO subscription status is 71.26x overall.
• The unofficial grey market premium recorded for Symbiotec Pharmalab Limited on 6 September 2026 is ₹204. This is not an exchange price and not a forecast of the listing price.
• The issue is open from 24-AUG-2026 to 27-AUG-2026.
• Symbiotec Pharmalab Limited listed on 01-SEP-2026.
• Symbiotec Pharmalab Limited listed at ₹1,095.95. The listing gain was 10.9% against the upper end of the issue price band.
• The registrar for this issue is MUFG Intime India Private Limited.

Symbiotec Pharmalab Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹938 – ₹988

Lot size

15 shares

Minimum investment

₹14,820

Issue size

₹1296.74 Cr

Fresh issue

₹150 Cr

Offer for sale

₹1607 Cr

Opens

24-AUG-2026

Closes

27-AUG-2026

Allotment

28-Aug-2026

Listing

01-SEP-2026

Total subscription

71.26x

Retail

12.96x

QIB

172.03x

NII

73.63x

Registrar

MUFG Intime India Private Limited

Lead managers

JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited

Listing price

₹1,095.95

Listing day change

+10.9%

Grey market premium: ₹204 (20.6%) — unofficial. GMP is a price quoted outside the exchanges in an unregulated market. It is not a listing price and not a forecast.

Other Pharmaceuticals IPOs

• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing
• Accretion Nutraveda Ltd. +48.2% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.